Abstract-The
Abstract-The effects of gomisin A, which is a lignan component of schizandra fruits, on liver functions in various experimental liver injuries and on bile secretion in CCl4-induced liver injury were studied. Gomisin A weakly accelerated the disappearance of plasma ICG by itself at a high dose (100 mg/kg, i.p.). All of the hepatotoxic chemicals used in this study inhibited the excretion of ICG from plasma. Gomisin A showed a tendency to prevent the delays of the disappearance of plasma ICG induced by CCl4, d-galactosamine and orotic acid, but not that by ANIT. Bile flow and biliary outputs of total bile acids and electrolytes (Na+, K+, Cl-and HC03-) were decreased in CC14-treated rats. Gomisin A maintained bile flow and biliary output of each electrolyte nearly to the level of the vehicle-treated group, but did not affect biliary output of total bile acids. These findings suggest that gomisin A possesses a liver function-facilitating property in normal and liver injured rats and that its preventive action on CC14-induced cholestasis is due to maintaining the function of the bile acids-independent fraction.
We previously reported that gomisin A, schizandrin and their analogues, which are lignan components of schizandra fruits, showed preventive effects on some experi mental liver injuries in serum-biochemical and histopathological examinations (1). The efficacy of gomisin A was the most prominent among the lignan components. The contents of Gomisin A in schizandra fruits is ca. 0.24 dry wt.% (2).
In ICG-distilled water solution was injected via the femoral vein, and about 120 /d of blood was collected from the tail vein using a hematocrit tube (Terumo, Tokyo, Japan) at 5, 10, 20, 30, 40, 50 and 60 min after the injection. Each blood sample was centrifuged at 10,000 rpm for 5 min, using a centrifuge for hematocrit determination (Kubota/Model KH-120), to obtain the plasma. Forty l of plasma was added with 2 ml of distilled water, and the absorbance at 805 nm was measured by using a spectrophotometer (Hitachi/Model 101). The amount of ICG was calculated from the previously constructed calibration curve.
1 -b) Effects on plasma ICG in CCI4 treated rats: The material (12.5-50 mg/kg) was administered i.p. and 4 ml/kg of 50% (V/V) CCI4-olive oil solution was orally (p.o.) given 30 min later. Twenty-four hr after the administration of CCI4, ICG was injected intravenously, and blood was periodically collected under anesthesia with pentobarbital-Na.
The amount of plasma ICG was measured according to the procedure described in 1 -a).
1 -c) Effects on plasma ICG in d galactosamine-treated rats: D-Galactosamine (400 mg/kg) was injected i.p. and the material (50 mg/kg) was also given i.p. 2 hr later. The measurement of the amount of plasma ICG was performed with the same procedure as 1 -a) 24 hr after the adminis tration of d-galactosamine.
1-d) Effects on plasma ICG in ANIT treated rats: Three ml/kg of 1.5% (W/V) ANIT-olive oil solution was given p.o. daily for 4 days. The material (50 mg/kg) was injected i.p. 30 min before every adminis tration of ANIT. The amount of plasma ICG was measured using the same procedure as 1-a) 24 hr after the last administration of AN IT.
1 -e) Effects on plasma ICG in orotic acid-treated rats: Two % (W/W) orotic acid containing food (Oriental Kobo Co., Japan) was given for 12 days. The material was administered by adding it to the orotic acid mixed food at the rate of 50 mg per 100 g. The measurement of the amount of plasma ICG was performed 24 hr after the last administration.
Effects of gomisin A on bile secretion in CCI4-treated rats
The material (50 mg/kg) was administered i.p. and 4 ml/kg of 50% (V/V) CCI4-olive oil solution was given p.o. 30 min later. Rats were laparotomized under anesthesia with pentobarbital-Na 24 hr after the adminis tration of CCI4. A polyethylene tube (PE-10) was inserted into the common bile duct to drain bile off freely, and after 10 min, the bile was collected for 60 min to measure the volume. Biliary concentration of total bile acids was measured using Sterognost-3a (Daiichi Chemical Pharmaceutical Co., Tokyo, Japan) and that of electrolytes (Na+, K+, CI and HCO3-) using Stat/Ion II (Technicon Instruments Co., New York, U.S.A.).
Statistical analysis
The values were expressed as the mean ±S.E. Statistical analysis was carried out using Student's t-test between the hepato toxic chemical-treated group and the gomisin A and hepatotoxic chemical-treated group.
Results

Effects of gomisin A on liver functions (ICG-clearance)
in various experimental liver injuries: a) Gomisin A slightly accelerated the disappearance of plasma ICG in normal rats 24 hr after the administration of 100 mg/kg, i. p., but not at 50 mg/kg, i.p. (Fig. 2) . Gomisin A (50 mg/kg, i.p.) and CCI4-treated group (n=8), -s-:
Vehicle-treated group (n=8). Data are expressed as the mean±S.E. *, ** and ***: Statistically significant difference from the CCI4-treated group at P<0.05, P<0.01 and P<0.001, respectively. b) CC14 (2 ml/kg, p.o.) markedly inhibited the excretion of ICG from plasma. This was dose-dependently prevented by the pre treatment with gomisin A (12.5-50 mg/kg, i.p.) (Fig. 3) . c) Gomisin A (50 mg/kg, i.p.) showed a tendency to prevent the delay of the disap pearance of plasma ICG which was caused by 400 mg/kg, i.p. of d-galactosamine (Fig.  4) . (Fig. 5) .
e) A tendency to inhibit the excretion of ICG was observed in rats fed the orotic acid containing food. The ICG level in plasma was maintained nearly to that of the normal food-treated group by the combined adminis tration of gomisin A with orotic acid (Fig. 6) .
2. Effects of gomisin A on bile secretion in CCI4-treated rats: Bile flow and billary outputs of total bile acids and electrolytes (Na+, K+, CI and HC03)
were decreased by the administration of CCI4 (2 ml/kg, p.o.). Bile flow and biliary output of each of the electrolytes in the gomisin A (50 ma/kg, i.p.) pretreated group showed values near to those in the vehicle-treated group, but the decrease of biliary output of total bile acids in CCI4-treated rats was not affected by gomisin A (Tables 1 and 2 ). 
Discussion
The effects of gomisin A, which is a lignan component of schizandra fruits, on liver functions in experimental liver injuries induced by CCI4, d-galactosamine, ANIT and orotic acid were studied using the ICG clearance test. Also, its effect on bile secretion in CC14-induced liver injury was examined using bile flow and biliary total bile acids and electrolytes (Na+, K+, CI and HC03) as parameters.
LD50 values of gomisin A in mice are 390 mg/kg, i.p., 500 mg/kg, s.c. and 777 mg/kg, p.o., as reported in our previous paper (4).
Dyes such as ICG are actively taken up into the hepatocytes through the cell membranes from blood. This uptake mechanism is con sidered to be carrier-mediated (5). Therefore, the disappearance rate of ICG from blood indicates the condition of a liver function. Gomisin A slightly accelerated the disap pearance of plasma ICG by itself at a high dose (100 mg/kg, i.p.). This fact indicates that gomisin A possesses a liver function facilitating property. Each of the hepatotoxic chemicals used in this study depressed a liver function. CCI4, d-galactosamine and ANIT markedly inhibited the excretion of ICG from plasma. Orotic acid also showed a similar effect, but it was less pronounced as compared with those of the aforementioned three chemicals. CCI4 is considered to induce a hepatocellular injury and a fatty degeneration by CC13 free radical (6, 7); d galactosamine causes a necrosis by the depletion of hepatic uridine store (8); ANIT causes a 1ntrahepatic cholestasis by cholangitis (9); and orotic acid causes a fatty liver by the repression in transport of lipoproteins (10). Gomisin A showed a tendency to prevent the delays of the disappearance of plasma ICG which was caused by CC14, d galactosamine and orotic acid, but not that by ANIT. These findings suggest that gomisin A may protect a lowered liver function in parenchymal injuries, and such preventive effects of gomisin A on hepatotoxicities may have partly resulted from the protective action on the hepatocytes . (1 ) .
A cholestasis and the decreases in biliary output of total bile acids and electrolytes (Na+, K+, CI and HC03)
were observed after the administration of CC14. The pretreatment with gomisin A in CC14-treated rats maintained bile flow and biliary output of each electrolyte nearly to the levels of the vehicle-treated group, but did not affect biliary output of total bile acids. Besides, gomisin A has no choleretic action in normal rats (4). Canalicular bile consists of at least two fractions, one of which (bile acids-dependent fraction) is related to a secretion of bile acids. The other fraction (bile acids-independent fraction) is considered to result from active transport of Na+ into the bile canaliculi (11 13). From our results, it is probable that gomisin A has little effect on the biliary output of total bile acids and that its pre ventive effect on cholestasis is due to main taining the function of the bile acids independent fraction.
